Cerebrospinal Fluid Biomarkers in Diagnosing Alzheimer's Disease in Clinical Practice: An Illustration with 3 Case Reports

Analysis of the brain specific biomarkers amyloid β(42) (Aβ(42)) and total tau (t-tau) protein in cerebrospinal fluid (CSF) has a sensitivity and specificity of more than 85% for differentiating Alzheimer's Disease (AD) from non-demented controls. International guidelines are contradictory in t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Slats, Diane, Spies, Petra E., Sjögren, Magnus J.C., Verhey, Frans R.J., Verbeek, Marcel M., Olde Rikkert, Marcel G.M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: S. Karger AG 2010
Gaiak:
Published: February 2010
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2914365/
https://ncbi.nlm.nih.gov/pubmed/20689628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000286280
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak